Congenital heart disease and the liver

Hepatology

Volumn 56, Issue 3, 2012, Pages 1160-1169

  Asrani, Sumeet K ^a   Asrani, Nina S ^b   Freese, Deborah K ^b   Phillips, Sabrina D ^b   Warnes, Carole A ^b   Heimbach, Julie ^b   Kamath, Patrick S ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; LACTATE DEHYDROGENASE;

ACUTE CARDIAC DYSFUNCTION; ASCITES; CONGENITAL HEART DISEASE; DISEASE SEVERITY; FONTAN PROCEDURE; HEART FAILURE; HEART OUTPUT; HEART SURGERY; HEART TRANSPLANTATION; HIGH RISK POPULATION; HUMAN; HYPOXEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION TEST; LIVER NODULE; LIVER TRANSPLANTATION; OPERATION DURATION; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; REVIEW; VENOUS CONGESTION;

FONTAN PROCEDURE; HEART DISEASES; HUMANS; LIVER DISEASES;

EID: 84865545400     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25692     Document Type: Review

References (42)

1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol 2008; 52: e1-e121.
2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007; 115: 163-172.
3. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 2005; 46: 1-8.
4. Friedman LS. Pathogenesis of liver injury in circulatory failure. In: Basow DS, ed. UpToDate. Waltham, MA: UpToDate; 2011.
5. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000; 109: 109-113.
6. Webster GJ, Kurtovic J, Lowe SA, Riordan SM. Hepatic ischemia associated with coarctation of the aorta in pregnancy: key issues in differential diagnosis. Obstet Gynecol 2004; 104: 1151-1154.
7. Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. HEPATOLOGY 2003; 37: 393-400.
8. Shteyer E, Yatsiv I, Sharkia M, Milgarter E, Granot E. Serum transaminases as a prognostic factor in children post cardiac surgery. Pediatr Int 2011; 53: 725-728.
9. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240-248.
10. Davies RR, Chen JM, Mosca RS. The Fontan procedure: evolution in technique; attendant imperfections and transplantation for "failure." Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2011; 14: 55-66.
11. Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, et al. Hepatic changes in the failing Fontan circulation. Heart 2007; 93: 579-584.
12. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Sasaki N, Asano H, et al. Ventricular afterload and ventricular work in fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with blalock-taussig shunts. Circulation 2002; 105: 2885-2892.
13. Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP, et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol 2008; 61: 504-508.
14. Rockey DC. Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis 2008; 12: 939-962, xi.
15. Baek JS, Bae EJ, Ko JS, Kim GB, Kwon BS, Lee SY, et al. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 2010; 96: 1750-1755.
16. Wu FM, Ukomadu C, Odze RD, Valente AM, Mayer JE, Jr., Earing MG. Liver disease in the patient with fontan circulation. Congenit Heart Dis 2011; 6: 190-201.
17. Griffiths ER, Kaza AK, Wyler von Ballmoos MC, Loyola H, Valente AM, Blume ED, del Nido P. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg 2009; 88: 558-563.
18. Pike NA, Evangelista LS, Doering LV, Koniak-Griffin D, Lewis AB, Child JS. Clinical profile of the adolescent/adult Fontan survivor. Congenit Heart Dis 2011; 6: 9-17.
19. Camposilvan S, Milanesi O, Stellin G, Pettenazzo A, Zancan L, D'Antiga L. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 2008; 86: 177-182.
20. Mištinová J, Valacsai F, Varga I. Congenital absence of the portal vein-case report and a review of literature. Clin Anat 2010; 23: 750-758.
21. Stringer MD. The clinical anatomy of congenital portosystemic venous shunts. Clin Anat 2008; 21: 147-157.
22. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. HEPATOLOGY 2009; 49: 2087-2107.
23. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. HEPATOLOGY 2010; 51: 306.
24. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. HEPATOLOGY 2007; 46: 922-938.
25. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005; 129: 1348-1352.
26. Bryant T, Ahmad Z, Millward-Sadler H, Burney K, Stedman B, Kendall T, et al. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. Int J Cardiol 2010; 151: 268-272.
27. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. HEPATOLOGY 2011; 53: 1020-1022.
28. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008; 57: 1592-1596.
29. Garbanzo JP, Kasahara M, Egawa H, Ikeda T, Doi H, Sakamoto S, et al. Results of living donor liver transplantation in five children with congenital cardiac malformations requiring cardiac surgery. Pediatr Transplant 2006; 10: 923-927.
30. Gundling F, Seidl H, Gansera L, Schuster T, Hoffmann E, Kemkes BM, et al. Early and late outcomes of cardiac operations in patients with cirrhosis: a retrospective survival-rate analysis of 47 patients over 8 years. Eur J Gastroenterol Hepatol 2010; 22: 1466-1473.
31. Korzon T, Kruk J. [Late results of conservative treatment of fractures of the mandibular condyle]. [Article in Polish]. Czas Stomatol 1971; 24: 41-48.
32. Odim JN, Wu J, Laks H, Banerji A, Drant S. Cardiac surgery in children with end-stage liver disease awaiting liver transplantation. Ann Thorac Surg 2006; 81: 697-700.
33. Koivusalo AM, Pere P, Valjus M, Scheinin T. Laparoscopic cholecystectomy with carbon dioxide pneumoperitoneum is safe even for high-risk patients. Surg Endosc 2008; 22: 61-67.
34. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, Galantowicz ME, Lamour JM, Quaegebeur JM, Hsu DT. Cardiac transplantation after the Fontan or Glenn procedure. J Am Coll Cardiol 2004; 44: 2065-2072.
35. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464-470.
36. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007; 132: 1261-1269.
37. Manzoni D, D'Ercole C, Spotti A, Carrara B, Sonzogni V. Congenital heart disease and pediatric liver transplantation: complications and outcome. Pediatr Transplant 2007; 11: 876-881.
38. Concejero A, Chen CL, Liang CD, Wang CC, Wang SH, Lin CC, et al. Atrial septal defect in end-stage liver disease children before and after liver transplantation. Surgery 2008; 143: 271-277.
39. Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest 2011 Jul 21. doi: 10.1378/chest.11-0160.
40. Porrett PM, Desai SS, Timmins KJ, Twomey CR, Sonnad SS, Olthoff KM. Combined orthotopic heart and liver transplantation: the need for exception status listing. Liver Transpl 2004; 10: 1539-1544.
41. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, et al. Combined heart and liver transplantation: a single-center experience. Transplantation 2009; 88: 219-225.
42. Te HS, Anderson AS, Millis JM, Jeevanandam V, Jensen DM. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant 2008; 27: 753-759.